Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-10-26
|
pubmed:abstractText |
Anatomical, pharmacological and human post-mortem studies suggest the dopamine D3 receptor (DRD3) gene as a candidate for drug dependence. We thus performed an association study of the Bal I polymorphism at the DRD3 gene, including 54 opiate addicts and 70 controls. Opiate addicts had a higher sensation-seeking score (on the Zückerman scale) than controls (P = 0.001), particularly a subgroup (70%) who had a distinctly higher score, exceeding 24. There were no marked differences in genotypes between patients as a whole and controls. However, patients with a sensation-seeking score above 24 were more frequently homozygotes for both alleles than patients with a sensation-seeking score under 24 (P = 0.038) or controls (P = 0.034). Although obtained in a sample of limited size, these results suggest that the DRD3 gene may have a role in drug dependence susceptibility in individuals with high sensation-seeking scores. This hypothesis is consistent with the role of DRD3 in mediating responses to drugs of abuse in animals and the association of homozygosity at the Bal I polymorphism with drug abuse in schizophrenic patients (see companion article by Krebs et al).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DRD3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonucleases, Type II...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D3,
http://linkedlifedata.com/resource/pubmed/chemical/TGGCCA-specific type II...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1359-4184
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-6
|
pubmed:dateRevised |
2008-9-4
|
pubmed:meshHeading |
pubmed-meshheading:9702742-Adult,
pubmed-meshheading:9702742-Deoxyribonucleases, Type II Site-Specific,
pubmed-meshheading:9702742-France,
pubmed-meshheading:9702742-Genotype,
pubmed-meshheading:9702742-Homozygote,
pubmed-meshheading:9702742-Humans,
pubmed-meshheading:9702742-Male,
pubmed-meshheading:9702742-Morbidity,
pubmed-meshheading:9702742-Opioid-Related Disorders,
pubmed-meshheading:9702742-Personality,
pubmed-meshheading:9702742-Polymerase Chain Reaction,
pubmed-meshheading:9702742-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:9702742-Receptors, Dopamine D2,
pubmed-meshheading:9702742-Receptors, Dopamine D3,
pubmed-meshheading:9702742-Reference Values
|
pubmed:year |
1998
|
pubmed:articleTitle |
Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence.
|
pubmed:affiliation |
Service Hospitalo-Universitaire de Santé Mentale et Thérapeutique, Université René Descartes, Hôpital Sainte-Anne, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|